<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 43-year-old female was admitted with therapy-resistant <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> and an <z:e sem="disease" ids="C0000735" disease_type="Neoplastic Process" abbrv="">abdominal tumor</z:e> around the pancreatic head </plain></SENT>
<SENT sid="1" pm="."><plain>Laboratory data revealed <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> with a white blood cell count of 18200/microl, 25% atypical cells and an LDH of 13410 IU/l </plain></SENT>
<SENT sid="2" pm="."><plain>The bone marrow was comprised of 78.4 percent lymphoblastoid cells which were positive for CD10, CD19 and CD20, and the cytogenetic study of which demonstrated the presence of t(8;14) (q24;q32) and t(14;18) (q32;q21) in the same clone </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was diagnosed as having Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) with t(8;14) and t(14;18) </plain></SENT>
<SENT sid="4" pm="."><plain>Although CODOX-M and IVAC therapy combined with rituximab achieved complete remission, she died of rapid progressive disease during whole brain irradiation before autologous peripheral blood stem cell transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>Even if the intensive chemotherapy with rituximab is given adequately, durable remission may not be achieved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> with translocation of t(8;14) and t(14;18) </plain></SENT>
<SENT sid="6" pm="."><plain>A more effective therapy remains to be established for the treatment of this disease </plain></SENT>
</text></document>